|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | C12P 21/08 | (2006.01) |
| C07K 16/28 | (2006.01) | ||
| C12P 21/00 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| C07K 16/32 | (2006.01) | ||
| C07K 16/44 | (2006.01) |
| (11) | Number of the document | 2486141 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10822699.4 |
| Date of filing the European patent application | 2010-10-07 | |
| (97) | Date of publication of the European application | 2012-08-15 |
| (45) | Date of publication and mention of the grant of the patent | 2018-01-10 |
| (46) | Date of publication of the claims translation | 2018-05-25 |
| (86) | Number | PCT/US2010/051831 |
| Date | 2010-10-07 |
| (87) | Number | WO 2011/044368 |
| Date | 2011-04-14 |
| (30) | Number | Date | Country code |
| 249510 P | 2009-10-07 | US |
| (72) |
JOHNSON, Leslie, S., US
RAINEY, Godfrey, Jonah, Anderson, US
LERNER, Laura, US
GORLATOV, Sergey, US
|
| (73) |
MacroGenics, Inc.,
9704 Medical Center Drive, Rockville, MD 20850,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Fc regioną turintys polipeptidai, pasižymintys pagerinta efektorine funkcija dėl fukozilinimo laipsnio pasikeitimų, ir jų naudojimo būdai |
| FC REGION-CONTAINING POLYPEPTIDES THAT EXHIBIT IMPROVED EFFECTOR FUNCTION DUE TO ALTERATIONS OF THE EXTENT OF FUCOSYLATION, AND METHODS FOR THEIR USE |
| Payment date | Validity (years) | Amount | |
| 2020-09-24 | 11 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2021-02-01 |